Monotoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas.
about
Improved completion rates and characterization of drug reactions with an intensive Chagas disease treatment program in rural BoliviaProtocol for SAMS (Support and Advice for Medication Study): a randomised controlled trial of an intervention to support patients with type 2 diabetes with adherence to medication.Performance of two questionnaires to measure treatment adherence in patients with Type-2 diabetesImproving medication adherence in diabetes type 2 patients through Real Time Medication Monitoring: a randomised controlled trial to evaluate the effect of monitoring patients' medication use combined with short message service (SMS) remindersThe utility of an electronic adherence assessment device in type 2 diabetes mellitus: a pilot study of single medicationPatterns of Adherence to Oral Hypoglycemic Agents and Glucose Control among Primary Care Patients with Type 2 Diabetes.Understanding how adherence goals promote adherence behaviours: a repeated measure observational study with HIV seropositive patientsMedication adherence: WHO cares?Compliance, clinical outcome, and quality of life of patients with stable angina pectoris receiving once-daily betaxolol versus twice daily metoprolol: a randomized controlled trial.Association between sitagliptin adherence and self-monitoring of blood glucose.Impact of reducing dosing frequency on adherence to oral therapies: a literature review and meta-analysisA scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence.Adherence to glyburide and metformin and associated factors in type 2 diabetes in isfahan, iran.Can technology improve adherence to long-term therapies?
P2860
Q28533625-E71354B7-00E6-4FE0-BADD-A5A0B4C12B5CQ33327739-A7C8A79B-B5E0-49C2-8C7D-99386F8A934DQ33403086-AD17ACE1-F086-4756-9398-CE4D11BD9808Q33789527-6141A4E5-A51D-4782-8AAB-9969ED80BC47Q34042008-9EFA4FB3-F515-4493-9542-C5510AF2A276Q34255735-B2344AE0-70A8-4D77-B861-D50AA4DD6EF0Q34361941-56A4C03B-9096-4817-A238-67EAA7D73E01Q34627451-37C25EBB-558F-422D-B187-1B9581E06141Q36013094-F92C0AF0-D3B5-4689-913B-861BCD135AC3Q36228968-CF7C01F6-0620-4CE2-BF84-B3904583BBEAQ36891527-03AD41D4-2C7C-4A37-BA6B-7485DC1E1590Q37030734-54A23DCD-1DE8-405C-BF6E-191A74D5C7CCQ37268117-19148963-D1B3-4D09-B8DC-16F8CF9C0612Q42599180-36DE7714-F13B-4506-AB86-500A19D66C51
P2860
Monotoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Monotoring adherence to prescr ...... ts treated with sulfonylureas.
@en
Monotoring adherence to prescr ...... ts treated with sulfonylureas.
@nl
type
label
Monotoring adherence to prescr ...... ts treated with sulfonylureas.
@en
Monotoring adherence to prescr ...... ts treated with sulfonylureas.
@nl
prefLabel
Monotoring adherence to prescr ...... ts treated with sulfonylureas.
@en
Monotoring adherence to prescr ...... ts treated with sulfonylureas.
@nl
P2093
P1433
P1476
Monotoring adherence to prescr ...... ts treated with sulfonylureas.
@en
P2093
Adrian U Teuscher
Annette Winkler
Bruno Mueller
Peter Diem
P304
P577
2002-07-01T00:00:00Z